MA39449A1 - Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci - Google Patents

Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci

Info

Publication number
MA39449A1
MA39449A1 MA39449A MA39449A MA39449A1 MA 39449 A1 MA39449 A1 MA 39449A1 MA 39449 A MA39449 A MA 39449A MA 39449 A MA39449 A MA 39449A MA 39449 A1 MA39449 A1 MA 39449A1
Authority
MA
Morocco
Prior art keywords
optically active
salts
obtaining enantiomers
pirlindole
active pirlindole
Prior art date
Application number
MA39449A
Other languages
English (en)
Inventor
Filipe Augusto Eugénio Pardal
Pedroso Pedro Filipe Eufrásio
Pecorelli Susana Marques Almeida
Caixado Carlos Alberto Eufrásio Casimiro
Ana Sofia Da Conceição Lopes
João Carlos Ramos Damil
Oliveira Santos Pedro Paulo De Lacerda E
Original Assignee
Tecnimede Soc Tecnico-Medicinal S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Soc Tecnico-Medicinal S A filed Critical Tecnimede Soc Tecnico-Medicinal S A
Publication of MA39449A1 publication Critical patent/MA39449A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Abstract

La présente invention concerne un nouveau procédé d'obtention d'énantiomères de pirlindole optiquement actifs, sous forme d'une base libre ou sous forme de sels pharmaceutiquement acceptables. Les produits obtenus selon la présente invention sont énantiomériquement purs et sont utiles en médecine.
MA39449A 2014-05-09 2014-05-09 Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci MA39449A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PT2014/000027 WO2015171003A1 (fr) 2014-05-09 2014-05-09 Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci

Publications (1)

Publication Number Publication Date
MA39449A1 true MA39449A1 (fr) 2017-11-30

Family

ID=50819929

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39449A MA39449A1 (fr) 2014-05-09 2014-05-09 Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci

Country Status (30)

Country Link
US (1) US9682986B2 (fr)
EP (1) EP3140265B1 (fr)
JP (1) JP6516769B2 (fr)
KR (1) KR102258709B1 (fr)
CN (1) CN106414376B (fr)
AU (1) AU2014393488C1 (fr)
BR (1) BR112016025918B1 (fr)
CA (1) CA2948604C (fr)
CY (1) CY1122367T1 (fr)
DK (1) DK3140265T3 (fr)
EC (1) ECSP16086217A (fr)
ES (1) ES2753403T3 (fr)
HR (1) HRP20192029T1 (fr)
HU (1) HUE046437T2 (fr)
IL (1) IL248853B (fr)
LT (1) LT3140265T (fr)
MA (1) MA39449A1 (fr)
MX (1) MX357918B (fr)
NZ (1) NZ726129A (fr)
PH (1) PH12016502234B1 (fr)
PL (1) PL3140265T3 (fr)
PT (1) PT3140265T (fr)
RS (1) RS59499B1 (fr)
RU (1) RU2666731C2 (fr)
SA (1) SA516380265B1 (fr)
SI (1) SI3140265T1 (fr)
TN (1) TN2016000496A1 (fr)
UA (1) UA118696C2 (fr)
WO (1) WO2015171003A1 (fr)
ZA (1) ZA201607722B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015171003A1 (fr) 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci
WO2015171002A1 (fr) * 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Sels pharmaceutiquement acceptables d'énantiomères de pirlindole s'utilisant en médecine
EP3392250A1 (fr) * 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Procedé pour la préparation de l'anneau de pipérazine pour la synthèse de pyrazinocarbazole
EP3392251A1 (fr) 2017-04-21 2018-10-24 Tecnimede-Sociedade Tecnico-Medicinal, S.A. Procedé pour la préparation des enantiomères de pirlindole et leurs sels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2281085C2 (ru) * 2004-05-25 2006-08-10 Закрытое акционерное общество "Мастерлек" Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
WO2015171003A1 (fr) 2014-05-09 2015-11-12 Tecnimede Sociedade Tecnico-Medicinal S.A. Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci

Also Published As

Publication number Publication date
UA118696C2 (uk) 2019-02-25
JP6516769B2 (ja) 2019-05-22
BR112016025918B1 (pt) 2023-05-16
NZ726129A (en) 2019-03-29
PH12016502234A1 (en) 2017-01-09
RU2666731C2 (ru) 2018-09-12
TN2016000496A1 (en) 2018-04-04
EP3140265B1 (fr) 2019-08-28
CN106414376B (zh) 2019-06-07
AU2014393488A1 (en) 2016-11-24
ES2753403T3 (es) 2020-04-08
SA516380265B1 (ar) 2019-11-04
MX2016014703A (es) 2017-05-23
US20170145024A1 (en) 2017-05-25
MX357918B (es) 2018-07-30
ZA201607722B (en) 2022-05-25
IL248853B (en) 2020-01-30
RS59499B1 (sr) 2019-12-31
US9682986B2 (en) 2017-06-20
RU2016148181A (ru) 2018-06-13
CA2948604C (fr) 2021-06-15
AU2014393488B2 (en) 2018-11-08
PT3140265T (pt) 2019-12-02
RU2016148181A3 (fr) 2018-06-13
KR102258709B1 (ko) 2021-06-01
PH12016502234B1 (en) 2017-01-09
ECSP16086217A (es) 2017-02-24
PL3140265T3 (pl) 2020-02-28
WO2015171003A1 (fr) 2015-11-12
HRP20192029T1 (hr) 2020-02-07
SI3140265T1 (sl) 2019-12-31
EP3140265A1 (fr) 2017-03-15
KR20170004995A (ko) 2017-01-11
IL248853A0 (en) 2017-01-31
LT3140265T (lt) 2019-12-10
HUE046437T2 (hu) 2020-03-30
CY1122367T1 (el) 2021-01-27
DK3140265T3 (da) 2019-11-18
CN106414376A (zh) 2017-02-15
BR112016025918A2 (fr) 2017-08-15
CA2948604A1 (fr) 2015-11-12
JP2017514883A (ja) 2017-06-08
AU2014393488C1 (en) 2020-07-16

Similar Documents

Publication Publication Date Title
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
CY1121062T1 (el) Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου alzheimer
GEP20186892B (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
MX2016010056A (es) 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso.
MX2019000536A (es) Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
MX2016011105A (es) Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos.
MX2018004664A (es) Antagonistas de ep4.
MA39449A1 (fr) Procédé d'obtention d'énantiomères de pirlindole optiquement actifs et de sels de ceux-ci
EP4249071A3 (fr) Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton
DOP2018000103A (es) Forma cristalina de 2-(2,6-diclorofenil)-1-[(1s,3r)-3-(hidroximetil)-5-(3-hidroxi-3-metilbutil)-1-metil-3,4-dihidroisoquinolin-2(1h)-il]etanona para tratar enfermedad de parkinson.
MX2015001917A (es) Composiciones farmaceuticas de memantina.
EA201790315A1 (ru) Модуляторы x-рецепторов печени
PH12015502676A1 (en) 4-(5-(4-chlorophenyl)-2-(2-cyclopropylacetyl)-1,4-dimethyl-1h-pyrrol-3-yl)benzenesulfonamide as alpha 7 nachr modulator
TR201819805T4 (tr) Flavaglin türevleri̇.
PH12016502235A1 (en) Pharmaceutically acceptable salts of pirlindole enantiomers for use in medicine
TN2017000448A1 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease
PH12016502527B1 (en) Stabilized desmopressin
PH12020500385A1 (en) A process for preparation of triaminopyrimidine compound and intermediates thereof
PE20170522A1 (es) Forma polimorfica novedosa del clorhidrato de n-[2-(6-fluoro-1h-indol-3-il)etil]-3-(2,2,3,3-tetrafluoropropoxi) bencilamina para el tratamiento del alzheimer
PH12019502792A1 (en) Tetrahydropyridopyrazine modulators of gpr6
BR112017003430A2 (pt) comprimido revestido com filme para o tratamento de dor aguda
FR3028760B1 (fr) Composition cosmetique de soin et/ou de maquillage de la peau